Current and emerging therapies for PNETs in patients with or without MEN1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current and emerging therapies for PNETs in patients with or without MEN1
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 14, Issue 4, Pages 216-227
Publisher
Springer Nature
Online
2018-02-16
DOI
10.1038/nrendo.2018.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
- (2017) James Yao et al. OncoTargets and Therapy
- Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
- (2017) K E Lines et al. Oncogenesis
- A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control
- (2017) K E Lines et al. Endocrine Connections
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers
- (2016) Johanna C. Bendell et al. CANCER INVESTIGATION
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
- (2016) Martyn E Caplin et al. ENDOCRINE-RELATED CANCER
- Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
- (2016) Gerard V. Walls et al. ENDOCRINOLOGY
- Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
- (2016) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Animal models of multiple endocrine neoplasia
- (2016) Tobias Wiedemann et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Chemoprevention of hereditary colon cancers: time for new strategies
- (2016) Luigi Ricciardiello et al. Nature Reviews Gastroenterology & Hepatology
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
- (2016) Anja Rinke et al. NEUROENDOCRINOLOGY
- Epigenomic regulation of oncogenesis by chromatin remodeling
- (2016) R Kumar et al. ONCOGENE
- AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas
- (2016) Tracey L. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternate dosing schedules for cancer chemopreventive agents
- (2016) Matteo Lazzeroni et al. SEMINARS IN ONCOLOGY
- Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years
- (2016) Paola Concolino et al. Cancer Genetics
- Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model
- (2015) R. Bill et al. CLINICAL CANCER RESEARCH
- Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors
- (2015) A. Dasari et al. ENDOCRINE-RELATED CANCER
- Conditional Deletion ofMen1in the Pancreatic β-Cell Leads to Glucagon-Expressing Tumor Development
- (2015) Feng Li et al. ENDOCRINOLOGY
- Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases
- (2015) Charlotte Ebeling Barbier et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sequencing and Combining Systemic Therapies for Pancreatic Neuroendocrine Tumors
- (2015) Matthew H. Kulke JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
- (2015) Timothy J. Hobday et al. JOURNAL OF CLINICAL ONCOLOGY
- Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
- (2015) Jack Cuzick et al. LANCET ONCOLOGY
- Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
- (2015) Alexandria T Phan et al. LANCET ONCOLOGY
- Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors
- (2015) James C. Yao et al. PANCREAS
- Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
- (2015) Catherine Lombard-Bohas et al. PANCREAS
- Genetics of pancreatic neuroendocrine tumors: implications for the clinic
- (2015) Antonio Pea et al. Expert Review of Gastroenterology & Hepatology
- Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1
- (2015) Christopher J Yates et al. Lancet Diabetes & Endocrinology
- Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
- (2014) Alfredo Berruti et al. BMC CANCER
- Current Status of Interventional Radiology in the Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs)
- (2014) Gianluigi Orgera et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
- (2014) V. Ramundo et al. CLINICAL ENDOCRINOLOGY
- Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
- (2014) M Cives et al. ENDOCRINE-RELATED CANCER
- Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial
- (2014) Michel Ducreux et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
- (2014) Emmanuel Mitry et al. EUROPEAN JOURNAL OF CANCER
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
- (2014) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Menin determines K-RAS proliferative outputs in endocrine cells
- (2014) Chester E. Chamberlain et al. JOURNAL OF CLINICAL INVESTIGATION
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast-Cancer Predisposition in Multiple Endocrine Neoplasia Type 1
- (2014) Koen M.A. Dreijerink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiofrequency Ablation of Pancreatic Neuroendocrine Tumors
- (2014) Sandro Rossi et al. PANCREAS
- The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors
- (2014) C Wong et al. Cell Death & Disease
- Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours
- (2014) Xiuli Jiang et al. Nature Communications
- Multiple Microvascular Alterations in Pancreatic Islets and Neuroendocrine Tumors of a Men1 Mouse Model
- (2013) Xia Chu et al. AMERICAN JOURNAL OF PATHOLOGY
- Epidemiology of gastroenteropancreatic neuroendocrine tumours
- (2013) M. Fraenkel et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study
- (2013) Marta Martín-Richard et al. BMC CANCER
- Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
- (2013) H K Ahn et al. BRITISH JOURNAL OF CANCER
- A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
- (2013) Jennifer A. Chan et al. CANCER
- Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome
- (2013) B. Gurung et al. CANCER RESEARCH
- A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors
- (2013) J R Strosberg et al. ENDOCRINE-RELATED CANCER
- Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1
- (2013) Tetsuhide Ito et al. MEDICINE
- Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
- (2013) Rajesh V. Thakker MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Treatment with the Radiolabelled Somatostatin Analog177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
- (2013) Maddalena Sansovini et al. NEUROENDOCRINOLOGY
- Menin: a scaffold protein that controls gene expression and cell signaling
- (2013) Smita Matkar et al. TRENDS IN BIOCHEMICAL SCIENCES
- A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
- (2012) J. R. Strosberg et al. ANNALS OF ONCOLOGY
- A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
- (2012) Diane L. Reidy-Lagunes et al. CANCER
- Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas
- (2012) Do-Youn Oh et al. CANCER
- Phase I-II Study of Radiopeptide 177Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine Tumors
- (2012) Phillip G. Claringbold et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas
- (2012) G. V. Walls et al. CANCER RESEARCH
- Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury
- (2012) Nikhil Bhagat et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Neuroendocrine tumor disease: an evolving landscape
- (2012) Andrea Frilling et al. ENDOCRINE-RELATED CANCER
- Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors
- (2012) Jennifer A Chan et al. ENDOCRINE-RELATED CANCER
- Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors
- (2012) Maxime Palazzo et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Impaired Transforming Growth Factor-β (TGF-β) Transcriptional Activity and Cell Proliferation Control of a Menin In-frame Deletion Mutant Associated with Multiple Endocrine Neoplasia Type 1 (MEN1)
- (2012) Lucie Canaff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interplay between Menin and K-Ras in Regulating Lung Adenocarcinoma
- (2012) Yuan Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
- (2012) Rajesh V. Thakker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
- (2012) Linda Villard et al. JOURNAL OF CLINICAL ONCOLOGY
- TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
- (2012) G. Rindi et al. JNCI-Journal of the National Cancer Institute
- The same pocket in menin binds both MLL and JUND but has opposite effects on transcription
- (2012) Jing Huang et al. NATURE
- ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
- (2012) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Angiogenesis in Neuroendocrine Tumors: Therapeutic Applications
- (2012) Jean-Yves Scoazec NEUROENDOCRINOLOGY
- Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
- (2012) Thomas J. Quinn et al. SURGERY
- New treatment options with cytotoxic agents in neuroendocrine tumours
- (2012) Pascal Hammel et al. Targeted Oncology
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the Liver
- (2011) Shantanu K. Gaur et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- New treatment strategies in advanced neuroendocrine tumours
- (2011) Thomas Walter et al. DIGESTIVE AND LIVER DISEASE
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner
- (2011) L. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
- (2010) Robert T. Jensen et al. CANCER
- The Tumor Suppressor Protein Menin Inhibits AKT Activation by Regulating Its Cellular Localization
- (2010) Yan Wang et al. CANCER RESEARCH
- Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1 - molecular pathways
- (2010) Mehtap Cakir et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Radiofrequency Ablation of Neuroendocrine Hepatic Metastasis
- (2010) T. Clark Gamblin et al. Surgical Oncology Clinics of North America
- Primary Lymph Node Gastrinoma or Occult Duodenal Microgastrinoma With Lymph Node Metastases in a MEN1 Patient
- (2009) Martin Anlauf et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients
- (2009) Jacqueline Trouillas et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Embolization as an Alternative Treatment of Insulinoma in a Patient with Multiple Endocrine Neoplasia Type 1 Syndrome
- (2009) Melpomeni Peppa et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia
- (2009) Brian Harding et al. ENDOCRINE-RELATED CANCER
- Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2009) Paul J. Newey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of -Catenin
- (2009) Y. Cao et al. MOLECULAR AND CELLULAR BIOLOGY
- Peptide-receptor radionuclide therapy for endocrine tumors
- (2009) Martijn van Essen et al. Nature Reviews Endocrinology
- Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients
- (2009) Pierre Goudet et al. WORLD JOURNAL OF SURGERY
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
- Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome
- (2008) C. R. C. Pieterman et al. CLINICAL ENDOCRINOLOGY
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now